Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director · Chairman and CEO · 10% owner | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.80 · Expires 2036-03-18 | Direct | 568,000 |
Reported balance
After 2026-03-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 100,000 · Balance 568,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 31, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.20 | $74.40 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 23 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,021 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 30, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.32 | $81.84 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 22 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,959 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 29, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.24 | $76.88 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 21 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,897 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 28, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.25 | $77.50 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 20 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,835 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 25, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.23 | $76.26 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 19 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,773 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 24, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.24 | $76.88 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 18 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,711 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 23, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.26 | $78.12 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 17 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,649 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 22, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.25 | $77.50 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 16 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,587 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 21, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.25 | $77.50 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 15 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,525 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 18, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.28 | $79.36 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 14 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,463 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 17, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.30 | $80.60 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 13 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,401 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 16, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.25 | $77.50 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 12 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,339 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 15, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.30 | $80.60 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 11 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,277 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 14, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.37 | $84.94 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 10 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,215 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 11, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.39 | $86.18 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 9 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,153 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 10, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.32 | $81.84 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 8 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,091 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 09, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.31 | $81.22 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 7 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,029 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 08, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.30 | $80.60 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 6 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,967 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 07, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.29 | $79.98 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 5 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,905 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 04, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.28 | $79.36 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 4 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,843 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 03, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.28 | $79.36 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 3 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,781 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 02, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.29 | $79.98 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,719 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 01, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.27 | $78.74 |
DisclosureSEC source: 0001628280-24-045329 · wk-form4_1730842732.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,657 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 30, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 62 | $1.36 | $84.32 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 20 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,595 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 27, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.24 | $54.56 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 19 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,533 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 26, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.24 | $62.00 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 18 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,489 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 25, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 39 | $1.29 | $50.31 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 17 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,439 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 24, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $1.22 | $18.30 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 16 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,400 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 23, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.25 | $62.50 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 15 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,385 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 20, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.30 | $65.00 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 14 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,335 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 19, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.29 | $64.50 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 13 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,285 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 18, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.30 | $65.00 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 12 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,235 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 17, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.30 | $65.00 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 11 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,185 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 16, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.30 | $65.00 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 10 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,135 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 13, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.30 | $65.00 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 9 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,085 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 12, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.38 | $69.00 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 8 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,035 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 11, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 48 | $1.35 | $64.80 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 7 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,985 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 10, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 31 | $1.30 | $40.30 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 6 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,937 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 09, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.33 | $66.50 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 5 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,906 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 06, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 10 | $1.30 | $13.00 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 4 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,856 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 05, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 46 | $1.28 | $58.88 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 3 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,846 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 04, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 47 | $1.35 | $63.45 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,800 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 03, 2024 Filed Oct 3, 2024 20:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.38 | $69.00 |
DisclosureSEC source: 0001628280-24-042115 · wk-form4_1727986047.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,753 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 27 | $1.35 | $36.45 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 21 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,703 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 29, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.41 | $70.50 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 20 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,676 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 28, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.40 | $70.00 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 19 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,626 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 27, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 29 | $1.40 | $40.60 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 18 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,576 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 26, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.37 | $68.50 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 17 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,547 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 23, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 42 | $1.38 | $57.96 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 16 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,497 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 22, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.40 | $61.60 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 15 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,455 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.